Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Price Reaction to Earnings Reports

View detailed tables showing price action before and after earnings announcements, ranging from intraday to one week out. Track how the market has reacted to past earnings to identify patterns and predict future behavior. Click here to open.

TECH

Bio-Techne Corp

Feb 05 • 12:53PM ET

76.37

Dollar change +3.82
Percentage change 5.26	%

Healthcare • Biotechnology • USA • NASD

Peers: TMO DHR ILMN A BIO QGEN NEO MTD

| Held by: VTI VOO VB VBK SPY RSP IVV XLV IBB VHT

Scroll to Statements

Index	S&P 500	P/E	81.39	EPS (ttm)	0.94	Insider Own	1.12%	Shs Outstand	158.88M	Perf Week	6.32%
Market Cap	12.13B	Forward P/E	34.94	EPS next Y	2.19	Insider Trans	-1.62%	Shs Float	157.11M	Perf Month	3.49%
Income	150.69M	PEG	6.65	EPS next Q	0.51	Inst Own	99.02%	Short Float	2.58%	Perf Quarter	1.40%
Sales	1.17B	P/S	10.36	EPS this Y	6.16%	Inst Trans	-0.60%	Short Ratio	4.35	Perf Half Y	-1.67%
Book/sh	13.46	P/B	5.67	EPS next Y	16.32%	ROA	5.49%	Short Interest	4.05M	Perf Year	15.74%
Cash/sh	1.18	P/C	64.70	EPS next 5Y	12.23%	ROE	7.29%	52W Range	61.16 - 85.57	Perf YTD	6.02%
Dividend Est.	0.26 (0.33%)	P/FCF	49.52	EPS past 5Y	11.13%	ROI	5.97%	52W High	-10.76%	Beta	1.27
Dividend TTM	0.32 (0.42%)	Quick Ratio	3.26	Sales past 5Y	10.61%	Gross Margin	66.22%	52W Low	24.86%	ATR (14)	2.98
Dividend Ex-Date	Nov 08, 2024	Current Ratio	4.56	EPS Y/Y TTM	-39.02%	Oper. Margin	20.88%	RSI (14)	55.25	Volatility	3.33% 3.70%
Employees	3100	Debt/Eq	0.19	Sales Y/Y TTM	2.41%	Profit Margin	12.86%	Recom	1.72	Target Price	85.58
Option/Short	Yes / Yes	LT Debt/Eq	0.18	EPS Q/Q	-33.77%	Payout	30.61%	Rel Volume	3.63	Prev Close	72.55
Sales Surprise	3.94%	EPS Surprise	8.75%	Sales Q/Q	4.52%	Earnings	Feb 05 BMO	Avg Volume	932.24K	Price	76.37
SMA20	1.61%	SMA50	2.43%	SMA200	2.31%	Trades		Volume	1,844,294	Change	5.26%

Date	Action	Analyst	Rating Change	Price Target Change
May-22-24	Downgrade	Citigroup	Buy → Neutral	$85
Feb-08-24	Initiated	Scotiabank	Sector Outperform	$80
Feb-02-24	Downgrade	Stifel	Buy → Hold	$65
Dec-07-23	Initiated	UBS	Buy	$80
Aug-28-23	Initiated	William Blair	Outperform
Jan-10-23	Upgrade	Wells Fargo	Underweight → Equal Weight	$90
Dec-14-22	Initiated	Deutsche Bank	Buy	$100
Dec-12-22	Upgrade	Citigroup	Neutral → Buy	$81.25 → $100
Dec-07-22	Initiated	RBC Capital Mkts	Sector Perform	$89
Aug-25-22	Initiated	Credit Suisse	Outperform	$465
Apr-25-22	Downgrade	Wells Fargo	Equal Weight → Underweight	$370
Sep-15-21	Upgrade	KeyBanc Capital Markets	Sector Weight → Overweight	$600
Mar-08-21	Upgrade	Stephens	Equal-Weight → Overweight	$380 → $425
Feb-23-21	Upgrade	Stifel	Hold → Buy	$435
Jan-25-21	Reiterated	The Benchmark Company	Buy	$320 → $410
Nov-10-20	Initiated	KeyBanc Capital Markets	Sector Weight	$340
Sep-30-20	Initiated	Atlantic Equities	Overweight	$365
Jul-15-20	Downgrade	Stephens	Overweight → Equal-Weight
May-27-20	Downgrade	Stifel	Buy → Hold	$245 → $260
May-14-20	Initiated	The Benchmark Company	Buy	$290

Show Previous Ratings

Today 06:41AM	Bio-Techne (NASDAQ:TECH) Surprises With Strong Q4, Stock Soars (StockStory) +5.26%
06:30AM	Bio-Techne Releases Second Quarter Fiscal 2025 Results (PR Newswire)
06:30AM	Bio-Techne Declares Dividend (PR Newswire)
Feb-04-25 07:00AM	Bio-Techne Appoints Dr. Amy E. Herr to Board of Directors (PR Newswire)
Jan-21-25 07:00AM	ScaleReady Announces a G-Rex Grant has been awarded to BrainChild Bio (PR Newswire)
07:00AM	Loading…
07:00AM	Bio-Techne to Host Conference Call on February 5, 2025, to Announce Second Quarter Fiscal 2025 Financial Results (PR Newswire)
Jan-10-25 07:00AM	Bio-Techne Expands RandD Systems AI-Engineered Designer Protein Portfolio to Advance Cell Therapy and Regenerative Medicine (PR Newswire)
07:00AM	Bio-Techne Expands R&D Systems AI-Engineered Designer Protein Portfolio to Advance Cell Therapy and Regenerative Medicine (PR Newswire)
Jan-08-25 07:00AM	ScaleReady Announces a G-Rex Grant has been awarded to Seattle Children's Therapeutics (PR Newswire)
07:00AM	BIO-TECHNE TO PRESENT AT PHACILITATE ADVANCED THERAPIES WEEK 2025 (PR Newswire)
Jan-07-25 07:00AM	BIO-TECHNE SUCCESSFUL ON SECOND CLAIM OF REVERSE ENGINEERING BY MILTENYI BIOTEC (PR Newswire)
Dec-20-24 07:00AM	BIO-TECHNE TO PRESENT AT THE 43rd ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE (PR Newswire)
Dec-19-24 07:00AM	BIO-TECHNE ANNOUNCES BIOTHERAPEUTIC CHARACTERIZATION STRATEGIC CO-MARKETING AND CO-PROMOTION AGREEMENT (PR Newswire)
Dec-18-24 07:00AM	ScaleReady awards a G-Rex Grant to Moonlight Bio (PR Newswire) -5.13%
Dec-12-24 07:00AM	BIO-TECHNE ANNOUNCES NEW DISTRIBUTION AGREEMENT WITH MEDSANTEK TO EXPAND ACCESS TO PORTFOLIO ACROSS TURKEY (PR Newswire)
07:00AM	Loading…
Dec-10-24 07:00AM	BIO-TECHNE LAUNCHES ESR1 MUTATION MONITORING ASSAY (PR Newswire)
Dec-09-24 07:33PM	Analyst Report: Bio-Techne Corporation (Morningstar Research)
Nov-29-24 11:32AM	Techne (TECH) Up 2.2% Since Last Earnings Report: Can It Continue? (Zacks)
Nov-27-24 07:00AM	BIO-TECHNE TO PRESENT AT THE CITI 2024 GLOBAL HEALTHCARE CONFERENCE (PR Newswire)
Nov-25-24 09:02AM	Gemini Bioproducts, LLC Acquires Selected Fetal Bovine Serum (FBS) Product Rights and Inventory from Bio-Techne (PR Newswire)
Nov-22-24 09:00AM	OverT Bio Receives $120K G-Rex Grant to Propel Solid Tumor Cell Therapy Advancements (Business Wire)
Nov-20-24 07:00AM	BIO-TECHNE ANNOUNCES NEW DISTRIBUTION AGREEMENT WITH LEADER LIFE SCIENCES (PR Newswire)
Nov-18-24 07:00AM	BIO-TECHNE AND ALZpath ANNOUNCE STRATEGIC PARTNERSHIP TO ADVANCE NEURODEGENERATIVE DISEASE RESEARCH (PR Newswire)
Nov-15-24 06:58PM	Analyst Report: Bio-Techne Corporation (Morningstar Research) -6.85%
Nov-14-24 07:00AM	BIO-TECHNE TO HIGHLIGHT NOVEL SOLUTIONS FOR CANCER AND CARRIER SCREENING AT AMP 2024 ANNUAL MEETING & EXPO (PR Newswire)
Nov-11-24 05:47PM	UPDATED: BIO-TECHNE ANNOUNCES IVDR CERTIFIED HEMATOLOGY CONTROLS AND CALIBRATORS (PR Newswire)
07:00AM	BIO-TECHNE ANNOUNCES IVDR CERTIFIED HEMATOLOGY CONTROLS AND CALIBRATORS (PR Newswire)
Nov-08-24 07:00AM	BIO-TECHNE TO PRESENT AT INVESTOR CONFERENCES (PR Newswire)
Nov-07-24 07:00AM	ScaleReady Announces multiple G-Rex Grants have been awarded to leading investigators at the Baylor College of Medicine's Center for Cell and Gene Therapy (PR Newswire)
Nov-06-24 07:00AM	BIO-TECHNE TO PRESENT AT THE SOCIETY FOR IMMUNOTHERAPY OF CANCER (SITC) 39TH ANNUAL MEETING (PR Newswire)
12:05AM	Loading…
12:05AM	Beyond the Balance Sheet: What SWOT Reveals About Bio-Techne Corp (TECH) (GuruFocus.com)
Nov-05-24 06:51PM	Analyst Report: Bio-Techne Corporation (Morningstar Research)
07:00AM	LUNAPHORE COMET PLATFORM PAVES THE WAY FOR SPATIAL BIOLOGY ADOPTION IN CLINICAL RESEARCH (PR Newswire)
Oct-31-24 10:39AM	Analyst Report: Bio-Techne Corporation (Morningstar Research)
03:08AM	Bio-Techne Corp (TECH) Q1 2025 Earnings Call Highlights: Navigating Growth and Challenges in a ... (GuruFocus.com)
01:01AM	Q1 2025 Bio-Techne Corp Earnings Call (Thomson Reuters StreetEvents)
Oct-30-24 06:30AM	BIO-TECHNE RELEASES FIRST QUARTER FISCAL 2025 RESULTS (PR Newswire) +7.46%
06:30AM	BIO-TECHNE DECLARES DIVIDEND (PR Newswire)
Oct-29-24 07:00AM	ScaleReady Announces a G-Rex Grant has been awarded to Luminary Therapeutics (PR Newswire)
Oct-17-24 06:57PM	Analyst Report: Bio-Techne Corporation (Morningstar Research)
Oct-10-24 07:00AM	BIO-TECHNE TO HOST CONFERENCE CALL ON OCTOBER 30, 2024, TO ANNOUNCE FIRST QUARTER FISCAL 2025 FINANCIAL RESULTS (PR Newswire)
Oct-09-24 08:00AM	Bio-Techne Announces 'The Simple Way to Advance Protein Research' Virtual Event Series (PR Newswire)
07:00AM	ScaleReady announces a G-Rex Grant has been awarded to LIfT Biosciences (PR Newswire)
Oct-08-24 04:25PM	Analyst Report: Bio-Techne Corporation (Morningstar Research)
07:00AM	ScaleReady announces a G-Rex Grant has been awarded to Dr. Eric Tran of the Earle A. Chiles Research Institute, a division of Providence Cancer Institute (PR Newswire)
Oct-07-24 07:00AM	ScaleReady announces a G-Rex Grant has been awarded to renowned cancer immunologist Dr. Christopher A. Klebanoff (PR Newswire)
Oct-03-24 05:34PM	S&P 500 Gains and Losses Today: Oil Stocks Rise as Global Tensions Escalate (Investopedia)
Sep-26-24 07:00AM	LUNAPHORE PARTNERS WITH DISCOVERY LIFE SCIENCES TO BRING INNOVATIVE SPATIAL BIOLOGY SOLUTIONS TO CLINICAL RESEARCH (PR Newswire)
Sep-24-24 07:00AM	BIO-TECHNE TO PRESENT AT NEUROSCIENCE 2024-THE SOCIETY FOR NEUROSCIENCE (SfN) ANNUAL MEETING (PR Newswire)
Sep-19-24 06:37PM	Analyst Report: Bio-Techne Corporation (Morningstar Research) +5.03%
Sep-18-24 07:00AM	ScaleReady announces a G-Rex Grant has been awarded to ImmunoScape (PR Newswire)
07:00AM	BIO-TECHNE ISSUES 2024 CORPORATE SUSTAINABILITY REPORT (PR Newswire)
Sep-17-24 07:00AM	Verismo Therapeutics Awarded a ScaleReady G-Rex Grant (PR Newswire)
07:00AM	ScaleReady announces a G-Rex Grant has been awarded to Verismo Therapeutics (PR Newswire)
Sep-16-24 07:00AM	ScaleReady and Bio-Techne Announce Optimal Closed System Cytokine Packaged for Single Step Use in Closed System G-Rex Manufacture of CAR-T and TCR Therapies (PR Newswire)
Sep-09-24 05:11AM	Heres What Dragged Bio-Techne Corporation (TECH)? (Insider Monkey)
Aug-27-24 07:00AM	ScaleReady announces the inaugural G-Rex Grant has been awarded to Stanford Medicine Laboratory for Cell and Gene Medicine (PR Newswire)
Aug-26-24 07:00AM	BIO-TECHNE TO PRESENT AT INVESTOR HEALTHCARE CONFERENCES (PR Newswire)
Aug-23-24 01:04AM	Beyond the Balance Sheet: What SWOT Reveals About Bio-Techne Corp (TECH) (GuruFocus.com)
Aug-08-24 02:28PM	Analyst Report: Bio-Techne Corporation (Morningstar Research)
Aug-07-24 07:20PM	Analyst Report: Bio-Techne Corporation (Morningstar Research) -9.51%
06:30AM	BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2024 RESULTS (PR Newswire)
06:30AM	BIO-TECHNE DECLARES DIVIDEND (PR Newswire)
Jul-31-24 07:00AM	BIO-TECHNE ANNOUNCES NEXT-GENERATION HIGH THROUGHPUT SIMPLE WESTERN SYSTEM (PR Newswire)
Jul-29-24 07:00AM	BIO-TECHNE ANNOUNCES STRATEGIC INVESTMENT IN SPEAR BIO (PR Newswire)
Jul-15-24 07:00AM	BIO-TECHNE TO HOST CONFERENCE CALL ON AUGUST 7, 2024, TO ANNOUNCE FOURTH QUARTER AND FISCAL 2024 FINANCIAL RESULTS (PR Newswire)
Jul-12-24 06:58PM	Analyst Report: Bio-Techne Corporation (Morningstar Research)
Jul-09-24 06:00AM	7 Cheap Biotech Stocks With Major Upside Potential (InvestorPlace)
Jul-02-24 07:06PM	Analyst Report: Bio-Techne Corporation (Morningstar Research)
May-31-24 07:00AM	BIO-TECHNE TO PRESENT AT UPCOMING INVESTOR CONFERENCES (PR Newswire)
May-30-24 07:00AM	BIO-TECHNE TO HIGHLIGHT MULTIPLE APPLICATIONS OF THE MauriceFlex SYSTEM AT THE ANNUAL ASMS CONFERENCE (PR Newswire)
May-29-24 07:00AM	ScaleReady Announces $20 Million G-Rex Grant Program for the Advancement of Cell and Gene Therapy (CGT) Development and Manufacturing (PR Newswire)
May-23-24 10:26AM	Multiple Headwinds Dragged Bio-Techne Corp. (TECH) in Q1 (Insider Monkey)
07:00AM	BIO-TECHNE TO PRESENT AT THE 2024 LEERINK PARTNERS HEALTHCARE CROSSROADS CONFERENCE (PR Newswire)
May-22-24 07:00AM	BIO-TECHNE HIGHLIGHTS RECENTLY ANNOUNCED TOP-LINE BIOMARKER DATA FROM PARTNER, REGULUS THERAPEUTICS, USING THE COMPANY'S PROPRIETARY TECHNOLOGY (PR Newswire)
May-20-24 01:34PM	7 Biotech Stocks That Could Breathe New Life Into Your Portfolio (InvestorPlace)
May-14-24 04:49AM	Bio-Techne Corporation (TECH) Declined on Weak Q4 Results (Insider Monkey)
May-08-24 07:00AM	BIO-TECHNE TO PRESENT AT THE BofA SECURITIES HEALTH CARE CONFERENCE 2024 (PR Newswire)
May-07-24 07:00AM	BIO-TECHNE TO PRESENT AT THE 27TH ANNUAL MEETING OF THE AMERICAN SOCIETY OF GENE & CELL THERAPY (ASGCT) (PR Newswire)
May-06-24 05:57AM	Argus Adjusts Price Target on Bio-Techne to $95 From $90, Keeps Buy Rating (MT Newswires)
May-02-24 11:40AM	Bio-Techne Corporation (NASDAQ:TECH) Q3 2024 Earnings Call Transcript (Insider Monkey)
11:31AM	UBS Adjusts Price Target on Bio-Techne to $90 From $80, Maintains Buy Rating (MT Newswires)
10:49AM	Leerink Partners Adjusts Price Target on Bio-Techne to $95 From $85 (MT Newswires)
10:34AM	Scotiabank Adjusts Price Target on Bio-Techne to $83 From $80 (MT Newswires)
08:17AM	RBC Capital Adjusts Price Target on Bio-Techne to $72 From $71, Sector Perform Rating Kept (MT Newswires)
08:00AM	Baird Adjusts Bio-Techne Price Target to $81 From $73 (MT Newswires)
03:11AM	Bio-Techne Corp (TECH) (Q3 2024) Earnings Call Transcript Highlights: Navigating Market ... (GuruFocus.com)
May-01-24 04:54PM	S&P 500 Gains and Losses Today: CVS Falls as Health Care Costs Pressure Profits (Investopedia) +16.22%
02:05PM	Top Midday Gainers (MT Newswires)
01:52PM	Bio-Techne Is the Best Performing Stock in the S&P 500 Wednesday. Heres Why. (Barrons.com)
12:08PM	Update: Bio-Techne Shares Jump After Fiscal Q3 Beat (MT Newswires)
11:10AM	Deutsche Bank Adjusts Price Target on Bio-Techne to $84 From $82 (MT Newswires)
09:30AM	Techne (TECH) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates (Zacks)
08:36AM	Bio-Techne's Fiscal Q3 Adjusted Earnings Fall, Net Sales Rise (MT Newswires)
07:51AM	Bio-Techne Corp (TECH) Q3 Fiscal 2024 Earnings: Mixed Results Amid Market Challenges (GuruFocus.com)
07:40AM	Techne (TECH) Q3 Earnings and Revenues Beat Estimates (Zacks)
07:29AM	Bio-Techne beats third-quarter estimates on improving demand for biotech products (Reuters)
06:30AM	BIO-TECHNE RELEASES THIRD QUARTER FISCAL 2024 RESULTS (PR Newswire)
06:30AM	BIO-TECHNE DECLARES DIVIDEND (PR Newswire)
Apr-30-24 07:00AM	BIO-TECHNE APPOINTS DR. JUDITH KLIMOVSKY TO BOARD OF DIRECTORS (PR Newswire)

Bio-Techne Corp. is a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities. Bio-Techne products assist scientific investigations into biological processes and the nature and progress of specific diseases. It operates through the Protein Sciences, and Diagnostics and Genomics segments. The Protein Sciences segment develops and manufactures purified proteins, and reagent solutions. The Diagnostics and Genomics segment develops and manufactures diagnostic products. The company was founded in 1976 and is headquartered in Minneapolis, MN.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
McManus Matthew	President - DGS	Feb 01 '25	Option Exercise	0.00	4,620	0	4,620	Feb 04 05:31 PM
Geist William	PRESIDENT, PROTEIN SCIENCES	Feb 01 '25	Option Exercise	0.00	3,320	0	14,401	Feb 04 05:27 PM
Kelderman Kim	Chief Executive Officer	Jan 27 '25	Option Exercise	37.70	13,392	504,878	52,396	Jan 29 04:35 PM
Kelderman Kim	Chief Executive Officer	Jan 27 '25	Sale	77.29	13,392	1,035,013	39,004	Jan 29 04:35 PM
KIM KELDERMAN	Director	Jan 27 '25	Proposed Sale	77.05	13,392	1,031,854		Jan 27 04:24 PM
Geist William	PRESIDENT, PROTEIN SCIENCES	Nov 01 '24	Option Exercise	0.00	9,912	0	14,351	Nov 05 04:48 PM
Hippel James	CFO	Nov 01 '24	Option Exercise	0.00	13,159	0	113,085	Nov 05 04:46 PM
HIGGINS JOHN L	Director	Sep 12 '24	Option Exercise	22.95	6,000	137,700	48,608	Sep 16 04:18 PM
Kelderman Kim	Chief Executive Officer	Aug 29 '24	Option Exercise	66.97	1,492	99,919	41,434	Sep 03 04:05 PM
Bohnen Shane	SVP - General Counsel	Aug 15 '24	Option Exercise	0.00	49	0	1,696	Aug 19 05:28 PM
BAUMGARTNER ROBERT V	Director	Aug 08 '24	Option Exercise	22.95	16,000	367,200	59,401	Aug 12 04:08 PM
BAUMGARTNER ROBERT V	Director	Aug 08 '24	Sale	72.10	16,000	1,153,664	43,401	Aug 12 04:08 PM
ROBERT V. BAUMGARTNER	Director	Aug 08 '24	Proposed Sale	72.10	16,000	1,153,664		Aug 08 04:13 PM
Hippel James	CFO	Aug 02 '24	Option Exercise	31.26	53,000	1,656,780	136,002	Aug 06 04:23 PM
Kelderman Kim	Chief Executive Officer	Jul 31 '24	Option Exercise	37.70	14,000	527,800	49,421	Aug 02 04:17 PM
Hippel James	CFO	Jul 23 '24	Option Exercise	31.26	35,000	1,094,100	107,284	Jul 25 04:31 PM
HIGGINS JOHN L	Director	Jul 08 '24	Option Exercise	22.95	6,000	137,700	42,608	Jul 10 04:35 PM
HIGGINS JOHN L	Director	May 14 '24	Option Exercise	22.95	4,000	91,800	40,608	May 16 04:17 PM
HIGGINS JOHN L	Director	May 14 '24	Sale	83.84	4,000	335,377	36,608	May 16 04:17 PM
Nusse Roeland	Director	Mar 07 '24	Sale	76.98	10,400	800,627	43,097	Mar 11 04:04 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

TECH

Bio-Techne Corp

Upgrade your FINVIZ experience